Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors

LONDON, Jan. 10, 2024 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the appointment of Robert W....

Related Keywords

London ,City Of ,United Kingdom ,Lauren Williams ,Robertw Azelby ,Bob Azelby ,Susana Noonan ,Julia Wilson ,Alder Biopharmaceuticals Inc ,Sa Noonan Communications ,Cascadian Therapeutics Inc ,Juno Therapeutics Inc ,Immunomedics Inc ,Nasdaq ,Amgen ,Clovis Oncology Inc ,Harvard Business School ,Management Team ,Eliem Therapeutics Inc ,Exchange Commission ,University Of Virginia ,Board Of Directors Chinook Therapeutics Inc ,Exchange Commission On ,Autolus Board ,Christian Itin ,Chief Executive Officer ,Eliem Therapeutics ,Alder Biopharmaceuticals ,Executive Vice President ,Chief Commercial Officer ,Juno Therapeutics ,Vice President ,General Manager ,Amgen Oncology ,Oncology Sales ,Commercial Effectiveness Unit ,Chinook Therapeutics Inc ,Cascadian Therapeutics ,Religious Studies ,Harvard Business ,Autolus Therapeutics ,Private Securities Litigation Reform Act ,Autolu Annual Report ,Markets ,